1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 27 JULY 2015

Cancer Drug News 27 JULY 2015

  • July 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Oncology Will Be Driving Force Of BMS' Revenues
Industry Brief - CASI Pharmaceuticals Launches Zevalin For NHL
Industry Brief - FDA Approval Sought For Arzerra As Maintenance Therapy For Relapsed CLL
Industry Brief - EMA Validates Empliciti MAA For MM
Industry Trend Analysis - Looming Competition Overshadows Kyprolis' Expanded Indication
Industry Brief - EC Approves Nivolumab BMS For Previously-Treated Advanced Squamous NSCLC
Industry Brief - Final NICE Guidance Recommends BI's Vargatef
Industry Brief - Ono Seeks NSCLC Approval For Opdivo In Japan
Industry Brief - Telesta/BL&H Sign South Korea MCNA Distribution Deal
Industry Trend Analysis - Opdivo Poised To Capitalise On Untapped RCC Market
Industry Brief - DSMB Recommends Continuation Of Enrolment In ERY-ASP Phase II PC Study
Industry Brief - AstraZeneca’s Selumetinib Phase III Study In Uveal Melanoma Misses Primary Endpoint
Industry Brief - Keytruda Gains EU Approval For Advanced Melanoma
Industry Brief - Tafinlar+Mekinist Gains CHMP Positive Opinion/FDA Priority Review For Advanced Melanoma
Industry Trend Analysis - US Biosimilar Market Tangible But Zarxio's Acceptance Will Be Challenging
Industry Trend Analysis - Resubmitted Sustol Will Be Growth Driver In CINV Drugs Market
Industry Brief - EMA Validates Two Parallel Type II Variation Applications To Extend Opdivo Indication
Industry Brief - Baxalta Completes Oncaspar Portfolio Acquisition From Sigma-Tau

Table Of Contents

Cancer Drug News 27 JULY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.